Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Benchmark in a research note issued on Wednesday, Benzinga reports. They currently have a $50.00 price objective on the stock. Benchmark’s price target indicates a potential upside of 103.83% from the company’s current price. A number of other […]
Benchmark reissued their buy rating on shares of Surgery Partners (NASDAQ:SGRY – Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a $50.00 target price on the stock. Other equities research analysts also recently issued research reports about the company. Citigroup decreased their price target on Surgery Partners from […]
Surgery Partners (NASDAQ:SGRY – Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07, MarketWatch Earnings reports. The firm had revenue of $735.40 million for the quarter, compared to analyst estimates of $741.93 million. Surgery Partners had […]
Clough Capital Partners L P lessened its holdings in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 31.7% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 137,903 shares of the company’s stock after selling 63,900 shares during the period. Clough Capital Partners L P owned 0.11% […]